Related references
Note: Only part of the references are listed.MicroRNA-506-3p increases the response to PARP inhibitors and cisplatin by targeting EZH2/fl-catenin in serous ovarian cancers
Yue Sun et al.
TRANSLATIONAL ONCOLOGY (2021)
MicroRNA-181d-5p-Containing Exosomes Derived from CAFs Promote EMT by Regulating CDX2/HOXA5 in Breast Cancer
Hongbin Wang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
The role of microRNAs in ovarian function and the transition toward novel therapeutic strategies in fertility preservation: from bench to future clinical application
C. Alexandri et al.
HUMAN REPRODUCTION UPDATE (2020)
Insight into the role of p62 in the cisplatin resistant mechanisms of ovarian cancer
Xiao-Yu Yan et al.
CANCER CELL INTERNATIONAL (2020)
microRNAs as biomarkers of ovarian cancer
Huilin Zhang et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2020)
Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism
Marie Angele Cucci et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines
Dominika Kazmierczak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
p62 Suppressed VK3-induced Oxidative Damage Through Keap1/Nrf2 Pathway In Human Ovarian Cancer Cells
Mei-hui Xia et al.
JOURNAL OF CANCER (2020)
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Amira A. Barkal et al.
NATURE (2019)
Increased expression of miR-181d is associated with poor prognosis and tumor progression of gastric cancer
Zhichun Li et al.
CANCER BIOMARKERS (2019)
Nrf2 induced cisplatin resistance in ovarian cancer by promoting CD99 expression
Jianfa Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
MiR-335-5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2
Ruonan Liu et al.
CANCER MEDICINE (2018)
Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer
Fuxing Zhou et al.
THERANOSTICS (2018)
miR-181 elevates Akt signaling by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast cancer
Michaela Strotbek et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
ABCF2, an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells
Lingjie Bao et al.
MOLECULAR CARCINOGENESIS (2017)
Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1+ colorectal cancer stem cells
Binghe Chen et al.
TUMOR BIOLOGY (2017)
miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer
Xiaofeng Guo et al.
CELL DEATH & DISEASE (2017)
Glycosylation of KEAP1 links nutrient sensing to redox stress signaling
Po-Han Chen et al.
EMBO JOURNAL (2017)
Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer
Miroslava Jurikova et al.
ACTA HISTOCHEMICA (2016)
Treatment of ovarian cancer beyond chemotherapy: Are we hitting the target?
Alvaro Henrique Ingles Garces et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer
Henan Zhao et al.
ONCOLOGY REPORTS (2015)
p62/SQSTM1 is involved in cisplatin resistance in human ovarian cancer cells via the Keap1-Nrf2-ARE system
Meihui Xia et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples
Markus Riester et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Estrogen Biosynthesis and Action in Ovarian Cancer
Felicitas Mungenast et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
miR-9 Regulation of BRCA1 and Ovarian Cancer Sensitivity to Cisplatin and PARP Inhibition
Chaoyang Sun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines
Lijuan Zhuo et al.
ONCOLOGY REPORTS (2013)
Share Paper
